Bioventure
Bioventure is a UAE-based biopharmaceutical company focused on biotechnology and pharmaceutical activities, delivering world-class solutions in the UAE and Middle East. It specializes in biotech and generics commercialization, technology transfer, and in/out-licensing activities. The company has exclusive distribution rights for Alvotech's biosimilar portfolio and Adalvo's targeted generic pharmaceuticals across the Middle East and Africa, with a portfolio including 13 biosimilars and 30 generic pharmaceuticals focused on oncology, autoimmune, inflammation, and blood diseases. Bioventure operates as part of GlobalOne Healthcare Holding, investing in life sciences to promote healthcare innovation and improve patient outcomes through partnerships and collaborations. It aims to drive short, medium, and long-term growth through product licensing, registration, acquisitions, and strategic investments, expanding its geographical presence globally while maintaining a strong regional footprint.
Bioventure
Bioventure is a UAE-based biopharmaceutical company focused on biotechnology and pharmaceutical activities, delivering world-class solutions in the UAE and Middle East. It specializes in biotech and generics commercialization, technology transfer, and in/out-licensing activities. The company has exclusive distribution rights for Alvotech's biosimilar portfolio and Adalvo's targeted generic pharmaceuticals across the Middle East and Africa, with a portfolio including 13 biosimilars and 30 generic pharmaceuticals focused on oncology, autoimmune, inflammation, and blood diseases. Bioventure operates as part of GlobalOne Healthcare Holding, investing in life sciences to promote healthcare innovation and improve patient outcomes through partnerships and collaborations. It aims to drive short, medium, and long-term growth through product licensing, registration, acquisitions, and strategic investments, expanding its geographical presence globally while maintaining a strong regional footprint.